BackThermo Fisher Scientific Overview
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific PEG Ratio

Valuation check: TMO's PEG ratio is 480.2, above the Healthcare sector average of 11.77.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

480.20

PEG Ratio

480.20

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Thermo Fisher Scientific (TMO) FAQ

Thermo Fisher Scientific (TMO) currently reports a PEG ratio of 480.2. That is above the Healthcare sector average of 11.77. Use the charts on this page to explore Thermo Fisher Scientific's PEG ratio history and peer comparisons.

Thermo Fisher Scientific's PEG ratio of 480.2 is higher than the Healthcare sector average of 11.77. That is roughly 3979.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Thermo Fisher Scientific's market price to a fundamental measure such as earnings, sales, or book value. At 480.2, TMO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 480.2, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.77. From there, open related valuation or income-statement pages for Thermo Fisher Scientific, and consider following TMO for alerts when major investors trade the stock.

Thermo Fisher Scientific is classified in the Healthcare sector. On PEG ratio, it currently shows 480.2 versus a sector average near 11.77. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TMO with unrelated industries.